share_log

AdvisorNet Financial Inc Boosts Stock Holdings in Proto Labs, Inc. (NYSE:PRLB)

Defense World ·  Sep 23, 2022 04:42

AdvisorNet Financial Inc raised its holdings in shares of Proto Labs, Inc. (NYSE:PRLB – Get Rating) by 1,108.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,100 shares of the industrial products company's stock after acquiring an additional 1,009 shares during the quarter. AdvisorNet Financial Inc's holdings in Proto Labs were worth $53,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of PRLB. Antonetti Capital Management LLC raised its holdings in Proto Labs by 84.5% during the 4th quarter. Antonetti Capital Management LLC now owns 524 shares of the industrial products company's stock valued at $27,000 after acquiring an additional 240 shares during the period. Hardy Reed LLC bought a new stake in Proto Labs during the 1st quarter valued at $30,000. Virginia Retirement Systems ET AL bought a new stake in Proto Labs during the 1st quarter valued at $201,000. Profund Advisors LLC bought a new stake in Proto Labs during the 1st quarter valued at $203,000. Finally, GSA Capital Partners LLP bought a new stake in Proto Labs during the 1st quarter valued at $204,000. Institutional investors own 88.86% of the company's stock.

Get Proto Labs alerts:

Analyst Ratings Changes

Several research analysts have recently weighed in on PRLB shares. Craig Hallum decreased their price target on shares of Proto Labs to $42.00 in a report on Monday, August 15th. StockNews.com raised shares of Proto Labs from a "hold" rating to a "buy" rating in a report on Monday, August 8th.

Proto Labs Stock Performance

Proto Labs stock opened at $36.64 on Friday. The stock has a market cap of $1.01 billion, a P/E ratio of 41.64 and a beta of 1.33. Proto Labs, Inc. has a fifty-two week low of $36.58 and a fifty-two week high of $79.27. The firm's fifty day moving average price is $43.40 and its 200-day moving average price is $46.32.

Proto Labs (NYSE:PRLB – Get Rating) last released its earnings results on Friday, August 5th. The industrial products company reported $0.46 EPS for the quarter, beating analysts' consensus estimates of $0.39 by $0.07. The business had revenue of $126.90 million for the quarter, compared to analysts' expectations of $127.28 million. Proto Labs had a return on equity of 2.95% and a net margin of 4.88%. The firm's revenue was up 3.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.47 earnings per share. Sell-side analysts predict that Proto Labs, Inc. will post 0.79 earnings per share for the current year.

About Proto Labs

(Get Rating)

Proto Labs, Inc, together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide. The company offers injection molding; computer numerical control machining; three-dimensional (3D) printing, which include stereolithography, selective laser sintering, direct metal laser sintering, multi jet fusion, polyjet, and carbon DLS processes; and sheet metal fabrication products, including quick-turn and e-commerce-enabled custom sheet metal parts.

See Also

  • Get a free copy of the StockNews.com research report on Proto Labs (PRLB)
  • The Institutions Hold On To Darden Restaurants International
  • What Steelcase's Earnings Say About the Return to the Office?
  • Is The Golden Age Of Homebuilding Already Over?
  • These 3 Big Dividend Payers Also Boast Strong Price Growth
  • Natural Gas Prices Continue To Rally, These Stocks Should Benefit

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment